Glaukos (GKOS) Reaches $30.49 After 3.00% Down Move; Shorts at Xcerra (XCRA) Lowered By 13.51%

March 14, 2018 - By Migdalia James

The stock of Glaukos Corporation (NYSE:GKOS) is a huge mover today! The stock decreased 3.97% or $1.26 during the last trading session, reaching $30.49. About 235,989 shares traded. Glaukos Corporation (NYSE:GKOS) has risen 54.04% since March 14, 2017 and is uptrending. It has outperformed by 37.34% the S&P500.The move comes after 8 months negative chart setup for the $1.06B company. It was reported on Mar, 14 by We have $29.58 PT which if reached, will make NYSE:GKOS worth $31.77M less.

Xcerra Corporation (NASDAQ:XCRA) had a decrease of 13.51% in short interest. XCRA’s SI was 834,700 shares in March as released by FINRA. Its down 13.51% from 965,100 shares previously. With 297,000 avg volume, 3 days are for Xcerra Corporation (NASDAQ:XCRA)’s short sellers to cover XCRA’s short positions. The SI to Xcerra Corporation’s float is 1.69%. The stock increased 2.55% or $0.28 during the last trading session, reaching $11.27. About 641,290 shares traded. Xcerra Corporation (NASDAQ:XCRA) has risen 65.92% since March 14, 2017 and is uptrending. It has outperformed by 49.22% the S&P500.

Among 7 analysts covering Glaukos Corporation (NYSE:GKOS), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Glaukos Corporation had 36 analyst reports since August 13, 2015 according to SRatingsIntel. Stifel Nicolaus upgraded the stock to “Buy” rating in Friday, January 6 report. The rating was initiated by Wells Fargo with “Outperform” on Thursday, October 27. BMO Capital Markets maintained Glaukos Corporation (NYSE:GKOS) rating on Wednesday, November 8. BMO Capital Markets has “Outperform” rating and $40 target. The rating was initiated by Roth Capital with “Buy” on Thursday, April 14. Roth Capital maintained the shares of GKOS in report on Wednesday, May 4 with “Buy” rating. As per Friday, June 3, the company rating was initiated by Cantor Fitzgerald. Stifel Nicolaus maintained Glaukos Corporation (NYSE:GKOS) on Monday, February 26 with “Buy” rating. The stock has “Buy” rating by Roth Capital on Wednesday, June 21. The rating was initiated by Stifel Nicolaus with “Hold” on Friday, April 8. The firm has “Buy” rating given on Thursday, September 14 by Stifel Nicolaus.

Analysts await Glaukos Corporation (NYSE:GKOS) to report earnings on May, 2. They expect $-0.12 EPS, down 700.00% or $0.14 from last year’s $0.02 per share. After $0.03 actual EPS reported by Glaukos Corporation for the previous quarter, Wall Street now forecasts -500.00% negative EPS growth.

Glaukos Corporation, an ophthalmic medical technology company, focuses on the development and commercialization of products and procedures designed to treat glaucoma. The company has market cap of $1.06 billion. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. It currently has negative earnings. The companyÂ’s product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry with the goal of achieving intraocular pressure reduction; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration.

Xcerra Corporation provides test and handling capital equipment, interface products, and test fixtures and related services to the semiconductor and electronics manufacturing industries worldwide. The company has market cap of $618.89 million. It operates through two divisions, Semiconductor Test Solutions and Electronic Manufacturing Solutions. It has a 13.78 P/E ratio. The firm offers Diamond series platform that offers high-density packaging for the testing of microcontrollers, and consumer and digital ASSP and ASIC devices; X-Series platform that offers configurations for the testing of analog ASSP and ASIC, power, automotive, mixed signal, and RF applications; and ASL platform for testing linear, low-end mixed signal, precision analog, and power management devices.

Among 5 analysts covering Xcerra (NASDAQ:XCRA), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Xcerra had 11 analyst reports since September 4, 2015 according to SRatingsIntel. Craig Hallum upgraded the stock to “Buy” rating in Friday, February 23 report. The stock of Xcerra Corporation (NASDAQ:XCRA) has “Hold” rating given on Monday, May 15 by Stifel Nicolaus. As per Friday, September 4, the company rating was maintained by DA Davidson. The stock of Xcerra Corporation (NASDAQ:XCRA) has “Hold” rating given on Monday, August 28 by B. Riley & Co. DA Davidson downgraded the shares of XCRA in report on Tuesday, April 11 to “Neutral” rating. Stifel Nicolaus maintained it with “Buy” rating and $8 target in Wednesday, November 18 report. The stock has “Buy” rating by DA Davidson on Friday, February 23. The company was upgraded on Friday, February 23 by Stifel Nicolaus. Needham maintained the stock with “Hold” rating in Wednesday, August 30 report. The firm earned “Neutral” rating on Tuesday, April 11 by B. Riley & Co.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: